O'Brien Greene & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
O'Brien Greene & Co's MDT Position: Q4 2023 in Review
O'Brien Greene & Co sold out of Medtronic (MDT) in Q4 2023, closing a stake of 51,617 shares — an estimated $4.04M sold.
O'Brien Greene & Co first reported a position in MDT in Q4 2018 and held it in 20 quarters. The position peaked at $14.7M in Q3 2022. 2,078 funds tracked by Wall St. Rank hold MDT as of Q4 2023.
- O'Brien Greene & Co reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
- O'Brien Greene & Co sold 51,617 Medtronic shares in Q4 2023, an estimated $4.04M.
- O'Brien Greene & Co first reported a position in Medtronic in Q4 2018 and held it in 20 quarters.
- O'Brien Greene & Co's Medtronic position peaked at $14.7M in Q3 2022.
- 2,078 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.
Based on O'Brien Greene & Co's 13F filing for Q4 2023, filed 2 Feb 2024.